Jonathan Kornstein | Vice President, Rare Disease and Pediatrics
CAIDYA

Jonathan Kornstein, Vice President, Rare Disease and Pediatrics, CAIDYA

Jonathan Kornstein is Vice President, Rare Disease and Pediatrics at Caidya and has over 29 years of expereince in the Pharmaceutical and CRO industry. He has demonstrated a depth of project management and clinical operations experience in a multitude of therapeutic areas with a focus on rare and pediatrics indications.  Jonathan provides strategic consultation and direction to clinical management, commerical development, and business development teams facilitating overall success in clinical trials.  Jonathan holds a bachelor's degree in biology from Hamilton College in Clinton, New York and is home based in Chapel Hill, North Carolina. Jonathan has experience in complex therapeutic areas focusing on Anaglgesia, Cardiovascular, Dermatology, Device, Endocrine/Metabolic, Gastrointestinal, Hepatology, Nephrology, Oncology, Pediatrics indications, Rare Diseases, Women's health, and Urology.  

Appearances:



Day 2 - Thursday 24 October @ 11:10

Panel: What are the impacts of rare designation?

last published: 13/Oct/24 14:15 GMT

back to speakers